Related Experiment Videos
[Herpes zoster--treatment with acyclovir]
J Jovanović1, D Cvjetković, M Pobor
1Klinika za infektivne i kozno-venericne bolesti, Medicinski fakultet, Novi Sad.
Medicinski Pregled
|July 1, 1997
Summary
Acyclovir treatment accelerates skin healing in herpes zoster patients. Early acyclovir initiation (within 6 days) significantly reduces acute herpetic neuralgia intensity and duration.
Area of Science:
- Virology
- Dermatology
- Pain Management
Context:
- Herpes zoster, a viral infection, causes painful skin lesions.
- Older adults and those with chronic conditions or stress are frequently affected.
- Acute herpetic neuralgia is a common complication, significantly impacting quality of life.
Purpose:
- To evaluate the efficacy of acyclovir in managing herpes zoster cutaneous manifestations.
- To determine the impact of acyclovir on the intensity and duration of acute herpetic neuralgia.
- To assess the influence of treatment initiation timing on patient outcomes.
Summary:
- Acyclovir therapy accelerated the resolution of cutaneous changes in herpes zoster patients, irrespective of the treatment phase (maculopapular, vesicular, or encrustation).
- The study involved 47 patients, primarily older women, with herpes zoster.
- Early initiation of acyclovir (within 6 days of onset) was associated with reduced pain intensity and complete cessation of neuralgia by hospital discharge.
Impact:
- Acyclovir demonstrates effectiveness in speeding up skin lesion healing in herpes zoster.
- Timely acyclovir administration is crucial for mitigating the severity and duration of acute herpetic neuralgia.
- Findings support early antiviral intervention for improved patient outcomes and reduced pain burden.